» Authors » Chi-Yuan Zhang

Chi-Yuan Zhang

Explore the profile of Chi-Yuan Zhang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 30
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao C, Zhang C, Yang X, Lam K, Xia Y, Du Y, et al.
Nat Prod Res . 2023 Oct; 39(3):550-558. PMID: 37902442
Oridonin is one of the -kaurane diterpenes that have been studied extensively for various bioactivities. In an effort to expand natural scaffold-based library as anticancer agents, we have designed and...
2.
Chen P, Zhang C
Front Oncol . 2022 Apr; 12:732322. PMID: 35433452
Objective: Increased risk of ovarian cancer (OC) among endometriosis patients has been proposed. However, the association between endometriosis and prognosis of OC remains controversial. This study evaluated whether endometriosis had...
3.
Lin D, Zhang C, Li L, Ye G, Jiang L, Jin Q
Cytogenet Genome Res . 2021 Oct; 161(8-9):414-424. PMID: 34649241
Atherosclerosis is the leading global cause of mortality. The occurrence of coronary artery disease (CAD) is regulated by a diversity of pathways, including circRNAs. However, the potential mechanisms of circRNAs...
4.
Yin H, Yan L, Liu Q, Peng Z, Zhang C, Xia Y, et al.
Sci Adv . 2020 Jun; 6(19):eaay9466. PMID: 32494702
The cardiac and hematopoietic progenitors (CPs and HPs, respectively) in the mesoderm ultimately form a well-organized circulation system, but mechanisms that reconcile their development remain elusive. We found that activating...
5.
Zhang C, Liu M, Wan J, Gao M, Zhang Y, Soyan M, et al.
Curr Top Med Chem . 2018 Jul; 18(12):975-986. PMID: 30027849
Pulmonary arterial hypertension (PAH) is a devastating disease without effective drugs available for its treatment. An in-depth exploration of the pathogenesis of PAH, as well as inquiry into potential therapeutic...
6.
Meng Z, Liu W, Xia Y, Yin H, Zhang C, Su D, et al.
Nat Commun . 2017 Mar; 8:14640. PMID: 28256502
Vasculogenic defects of great vessels (GVs) are a major cause of congenital cardiovascular diseases. However, genetic regulators of endothelial precursors in GV vasculogenesis remain largely unknown. Here we show that...